Agilon Health stock kpis
Want to see AGL full AI Analyst Report?
Revenue by Segment
In Q3 2026, Agilon Health reported revenue by segment of $1.66M (Other) and $1.52B (Medical Services).
Shows income generated from each business segment, providing insight into diverse revenue streams and strategic focus areas.
Medical Services is the clear revenue engine — recent gains reflect not just volume but a meaningful risk‑adjustment and coding uplift plus wins from CHF and ACO programs that swung medical margin and EBITDA materially positive. 'Other' is negligible. The key investor question: durability. Management’s enhanced data pipeline and clinical pathways improve visibility and justify raised guidance, but disciplined MA contracting, Part D exposure and ongoing cost‑trend assumptions leave 2027 membership/pricing and margin sustainability as the primary risks to watch.
AGL Revenue by Segment
| Period | Other | Medical Services |
|---|---|---|
| Q3 2026Sep 30, 2026 | $1.66M | $1.52B |
| Q2 2026Jun 30, 2026 | $1.82M | $1.49B |
| Q1 2026Mar 31, 2026 | $1.91M | $1.42B |
| Q4 2025Dec 31, 2025 | $2.50M | $1.57B |
| Q3 2025Sep 30, 2025 | $2.88M | $1.43B |
| Q2 2025Jun 30, 2025 | $2.94M | $1.39B |
| Q1 2025Mar 31, 2025 | $2.90M | $1.53B |
| Q4 2024Dec 31, 2024 | $3.24M | $1.52B |
| Q3 2024Sep 30, 2024 | $3.23M | $1.45B |
| Q2 2024Jun 30, 2024 | $3.18M | $1.48B |
| Q1 2024Mar 31, 2024 | $3.16M | $1.60B |
| Q4 2023Dec 31, 2023 | $2.53M | $1.05B |
| Q3 2023Sep 30, 2023 | $3.53M | $1.21B |
| Q2 2023Jun 30, 2023 | $2.01M | $1.15B |
| Q1 2023Mar 31, 2023 | $1.32M | $1.13B |
| Q4 2022Dec 31, 2022 | $919.00K | $688.86M |
| Q3 2022Sep 30, 2022 | $924.00K | $693.93M |
| Q2 2022Jun 30, 2022 | $950.00K | $669.18M |
| Q1 2022Mar 31, 2022 | $1.02M | $652.42M |
| Q4 2021Dec 31, 2021 | $887.00K | $462.00M |
| Q3 2021Sep 30, 2021 | $967.00K | $457.65M |
| Q2 2021Jun 30, 2021 | $1.28M | $497.68M |
| Q1 2021Mar 31, 2021 | $692.00K | $412.41M |
| Q4 2020Dec 31, 2020 | $780.00K | $320.23M |
| Q3 2020Sep 30, 2020 | $950.00K | $311.73M |
| Q2 2020Jun 30, 2020 | $1.10M | $292.50M |
| Q1 2020Mar 31, 2020 | $1.23M | $289.81M |

